Brentuximab vedotin with chemotherapy in adolescents and young adults with stage III or IV classical Hodgkin lymphoma in ECHELON-1

Howland E. Crosswell; Ann S. LaCasce; Nancy L. Bartlett; David J. Straus; Kerry J. Savage; Pier Luigi Zinzani; Graham P. Collins; Michelle Fanale; Keenan Fenton; Cassie Dong; Harry Miao; Andrew P. Grigg

doi:10.3324/haematol.2023.283303

Brentuximab vedotin with chemotherapy in adolescents and young adults with stage III or IV classical Hodgkin lymphoma in ECHELON-1

Howland E. Crosswell, Ann S. LaCasce, Nancy L. Bartlett, David J. Straus, Kerry J. Savage, Pier Luigi Zinzani, Graham P. Collins, Michelle Fanale, Keenan Fenton, Cassie Dong, Harry Miao, Andrew P. Grigg

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	982
Number of pages	1
Journal	Haematologica
Volume	109
Issue number	3
DOIs	https://doi.org/10.3324/haematol.2023.283303
State	Published - Mar 2024

Access to Document

10.3324/haematol.2023.283303

Cite this

Crosswell, H. E., LaCasce, A. S., Bartlett, N. L., Straus, D. J., Savage, K. J., Zinzani, P. L., Collins, G. P., Fanale, M., Fenton, K., Dong, C., Miao, H., & Grigg, A. P. (2024). Brentuximab vedotin with chemotherapy in adolescents and young adults with stage III or IV classical Hodgkin lymphoma in ECHELON-1. Haematologica, 109(3), 982. https://doi.org/10.3324/haematol.2023.283303

@article{6bcd2f19aa784ce8b65ef1944428c6cd,

title = "Brentuximab vedotin with chemotherapy in adolescents and young adults with stage III or IV classical Hodgkin lymphoma in ECHELON-1",

author = "Crosswell, {Howland E.} and LaCasce, {Ann S.} and Bartlett, {Nancy L.} and Straus, {David J.} and Savage, {Kerry J.} and Zinzani, {Pier Luigi} and Collins, {Graham P.} and Michelle Fanale and Keenan Fenton and Cassie Dong and Harry Miao and Grigg, {Andrew P.}",

year = "2024",

month = mar,

doi = "10.3324/haematol.2023.283303",

language = "English",

volume = "109",

pages = "982",

journal = "Haematologica",

issn = "0390-6078",

number = "3",

}

TY - JOUR

T1 - Brentuximab vedotin with chemotherapy in adolescents and young adults with stage III or IV classical Hodgkin lymphoma in ECHELON-1

AU - Crosswell, Howland E.

AU - LaCasce, Ann S.

AU - Bartlett, Nancy L.

AU - Straus, David J.

AU - Savage, Kerry J.

AU - Zinzani, Pier Luigi

AU - Collins, Graham P.

AU - Fanale, Michelle

AU - Fenton, Keenan

AU - Dong, Cassie

AU - Miao, Harry

AU - Grigg, Andrew P.

PY - 2024/3

Y1 - 2024/3

UR - http://www.scopus.com/inward/record.url?scp=85186743546&partnerID=8YFLogxK

U2 - 10.3324/haematol.2023.283303

DO - 10.3324/haematol.2023.283303

M3 - Letter

C2 - 37794803

AN - SCOPUS:85186743546

SN - 0390-6078

VL - 109

SP - 982

JO - Haematologica

JF - Haematologica

IS - 3

ER -

Brentuximab vedotin with chemotherapy in adolescents and young adults with stage III or IV classical Hodgkin lymphoma in ECHELON-1

Access to Document

Other files and links

Cite this